Reuters logo
BRIEF-Neovacs H1 net loss widens to 8.1‍​ million euros
October 27, 2017 / 4:04 PM / a month ago

BRIEF-Neovacs H1 net loss widens to 8.1‍​ million euros

Oct 27 (Reuters) - NEOVACS SA:

* H1 NET LOSS EUR 8.1‍​ MILLION VERSUS LOSS OF EUR 6.8 MILLION YEAR AGO

* H1 OPERATING LOSS EUR 10.2‍​ MILLION VERSUS LOSS OF EUR 7.9 MILLION YEAR AGO

* H1 REVENUE EUR ‍​0.5 MILLION VERSUS EUR 0.1 MILLION YEAR AGO

* ‍CASH AND CASH EQUIVALENTS AT JUNE 30, 2017, AMOUNTED TO EUR 1.8 MLN​

* ‍TO OBTAIN RESULTS FROM PHASE IIB CLINICAL TRIAL IN LUPUS IN JUNE 2018​‍​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below